159 related articles for article (PubMed ID: 4282697)
1. Fibrin-fibrinogen degradation products in allergic disorders.
Palma-Carlos AG; de Sá A; Joana-Geraldes M; Ducla-Soares J; Migueis-Clode MH
Allergol Immunopathol (Madr); 1974; 2(6):419-22. PubMed ID: 4282697
[No Abstract] [Full Text] [Related]
2. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
Fujimaki M; Ikematsu S; Takeuchi I
Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
[No Abstract] [Full Text] [Related]
3. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
Konttinen YP; Kemppainen L; Turunen O
Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
[No Abstract] [Full Text] [Related]
4. [A simple method for the determination of intravascular clotting and fibrinolysis].
Latallo ZS; Wegrzynowicz Z; Kopeć M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):32-5. PubMed ID: 4114580
[No Abstract] [Full Text] [Related]
5. [Fibrinolysis].
Levy G; Michault A; Jamet M
Ann Anesthesiol Fr; 1978; 19(8):703-8. PubMed ID: 31114
[TBL] [Abstract][Full Text] [Related]
6. [The plasma-protamine-paracoagulation-(3-P-) test].
Berkessy S
Z Gesamte Inn Med; 1974 Jun; 29(12):491-3. PubMed ID: 4849942
[No Abstract] [Full Text] [Related]
7. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
Lychev VG; Momot AP; Cherkashin GV
Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
[TBL] [Abstract][Full Text] [Related]
8. [Immunoelectrophoretic study of fibrinogen and of degradation products of fibrinogen and fibrin].
Karpinskaia VM
Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):53-6. PubMed ID: 5736826
[No Abstract] [Full Text] [Related]
9. Formation and detection of fibrinogen derived complexes.
Latallo ZS
Thromb Diath Haemorrh; 1975 Dec; 34(3):677-85. PubMed ID: 1209540
[No Abstract] [Full Text] [Related]
10. Defibrination in saline abortion.
Schwartz R; Greston W; Kleiner GJ
Obstet Gynecol; 1972 Nov; 40(5):728-37. PubMed ID: 5083225
[No Abstract] [Full Text] [Related]
11. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
[No Abstract] [Full Text] [Related]
12. Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products.
Niewiarowski S; Gurewich V
J Lab Clin Med; 1971 Apr; 77(4):665-76. PubMed ID: 4928905
[No Abstract] [Full Text] [Related]
13. Detection of hypercoagulable states with protamine sulphate tests.
Lipinski B
Acta Univ Carol Med Monogr; 1972; 52():185-8. PubMed ID: 4273929
[No Abstract] [Full Text] [Related]
14. [Specificity and sensitivity of paracoagulation tests].
Litvinov RI; Voronina IE; Gabitov SE
Lab Delo; 1980; (11):662-6. PubMed ID: 6160297
[No Abstract] [Full Text] [Related]
15. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
Shinada S
Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):607-16. PubMed ID: 4677376
[No Abstract] [Full Text] [Related]
16. [Effect of fibrin degradation products on different biological tests (author's transl)].
Vila V; Aznar J; Regañon E
Sangre (Barc); 1976; 21(4):814-26. PubMed ID: 1006498
[No Abstract] [Full Text] [Related]
17. [Fibrinolysis phenomenon (author's transl)].
Fujimaki M; Suzuki H; Yasui T; Yatabe M; Ikematsu S
Rinsho Byori; 1974 Aug; 22(Suppl):234-41. PubMed ID: 4610225
[No Abstract] [Full Text] [Related]
18. [Fibrinolysis activities and factor XIII in the neonatal period. 1. Fibrinolysis activity and fibrin degradation products in the neonatal period].
Yamada Z
Nihon Shonika Gakkai Zasshi; 1971 Apr; 75(4):294-6. PubMed ID: 4252802
[No Abstract] [Full Text] [Related]
19. [Improved standard fibrin plate method and development of methods for rapid analysis of fibrinogen-fibrin degradation products].
Honi S; Inaoka Y; Ishibashi K; Kawagoe H
Rinsho Byori; 1971 Aug; 19():Suppl:258. PubMed ID: 5290296
[No Abstract] [Full Text] [Related]
20. [Immunological demonstration of fibrinogen-fibrin break-down products in serum and urine. Clinical significance].
Gormsen J; Clausen NT
Ugeskr Laeger; 1973 Aug; 135(32):1682-7. PubMed ID: 4589773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
